Britt, Kara L. https://orcid.org/0000-0001-6069-7856
Cuzick, Jack https://orcid.org/0000-0001-7420-7512
Phillips, Kelly-Anne https://orcid.org/0000-0002-0475-1771
Article History
Accepted: 23 April 2020
First Online: 11 June 2020
Competing interests
: The authors wish to disclose that Cancer Research UK (CRUK) licences the International Breast Cancer Intervention Study (IBIS; also known as Tyrer–Cuzick) model for commercial use and J.C. receives some benefit. K.A.-P has a patent, System and Process of Cancer Risk Estimation (Australian Innovation Patent), issued regarding iPrevent. K.L.B has no competing interests.